Growth and Development Study of Alglucosidase Alfa

Clinical trial NCT00486889 · COMPLETED

Trial details

NCT number: NCT00486889
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pompe Disease Glycogen Storage Disease Type II (GSD-II)Acid Maltase Deficiency Disease

Start date: 2008-08-26
Primary completion: 2021-11-23
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.